• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与肥胖相关疾病治疗的医疗服务提供者对肥胖治疗的态度:一项对多个欧洲国家多个医学专业的调查。

Attitudes about the treatment of obesity among healthcare providers involved in the care of obesity-related diseases: A survey across medical specialties in multiple European countries.

作者信息

Rubino Francesco, Logue Jennifer, Bøgelund Mette, Madsen Maria Elmegaard, Cancino Ana-Paula, Høy Maria, Panton Ulrik Haagen

机构信息

Diabetes and Nutritional Sciences King's College London London UK.

Lancaster Medical School Lancaster University Lancaster UK.

出版信息

Obes Sci Pract. 2021 May 21;7(6):659-668. doi: 10.1002/osp4.518. eCollection 2021 Dec.

DOI:10.1002/osp4.518
PMID:34877005
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633947/
Abstract

BACKGROUND AND RATIONALE

Obesity is associated with the development and progression of many diseases. Understanding and management of obesity have become increasingly important; however, a knowledge gap remains between how healthcare providers (HCPs) consider weight-loss treatment and the importance of weight loss for improving obesity-related diseases.

OBJECTIVE

The objective of this study was to investigate how HCPs assess obesity, how they interpret the relationship between obesity and 12 recognized co-morbidities of obesity (excluding diabetes), and their view about the value of various weight-loss therapies.

METHODS

This was a cross-sectional, non-interventional, descriptive study. Participants were medical doctors (HCPs) from eight European countries.

RESULTS

Eighty-nine percent of the 197 HCPs that completed the survey considered obesity a disease. For most of the 12 obesity-related diseases under consideration, a majority of HCPs agreed that weight loss could reverse the disease or prevent progression. Among HCPs who have recommended weight loss, lifestyle interventions were by far the most common recommendation. However, more than three out of four HCPs stated that they would be likely to prescribe anti-obesity medications if available and reimbursed.

CONCLUSION

Most HCPs in this survey consider obesity a disease that needs to be treated. However, the majority of HCPs appear to prefer recommending lifestyle changes, although it is well documented that weight loss obtained by lifestyle changes is difficult to maintain. These results underscore the need for improved education of HCPs involved in the treatment of obesity-related diseases.

摘要

背景与理论依据

肥胖与多种疾病的发生和发展相关。对肥胖的理解和管理变得愈发重要;然而,在医疗服务提供者(HCPs)如何看待减肥治疗以及减肥对于改善肥胖相关疾病的重要性方面,仍存在知识差距。

目的

本研究的目的是调查HCPs如何评估肥胖,他们如何解读肥胖与12种公认的肥胖合并症(不包括糖尿病)之间的关系,以及他们对各种减肥疗法价值的看法。

方法

这是一项横断面、非干预性的描述性研究。参与者是来自八个欧洲国家的医生(HCPs)。

结果

完成调查的197名HCPs中,89%认为肥胖是一种疾病。对于所考虑的12种肥胖相关疾病中的大多数,大多数HCPs都认为减肥可以逆转疾病或预防疾病进展。在推荐过减肥的HCPs中,生活方式干预是迄今为止最常见的建议。然而,超过四分之三的HCPs表示,如果有可用且可报销的抗肥胖药物,他们很可能会开此类药物。

结论

本次调查中的大多数HCPs认为肥胖是一种需要治疗的疾病。然而,大多数HCPs似乎更倾向于推荐改变生活方式,尽管有充分的文献记载,通过改变生活方式实现的体重减轻很难维持。这些结果强调了对参与治疗肥胖相关疾病的HCPs进行强化教育的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/e335e2a8437a/OSP4-7-659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/d8699933b076/OSP4-7-659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/a3fe30577275/OSP4-7-659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/217d7fa918e2/OSP4-7-659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/e335e2a8437a/OSP4-7-659-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/d8699933b076/OSP4-7-659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/a3fe30577275/OSP4-7-659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/217d7fa918e2/OSP4-7-659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c097/8633947/e335e2a8437a/OSP4-7-659-g005.jpg

相似文献

1
Attitudes about the treatment of obesity among healthcare providers involved in the care of obesity-related diseases: A survey across medical specialties in multiple European countries.参与肥胖相关疾病治疗的医疗服务提供者对肥胖治疗的态度:一项对多个欧洲国家多个医学专业的调查。
Obes Sci Pract. 2021 May 21;7(6):659-668. doi: 10.1002/osp4.518. eCollection 2021 Dec.
2
ACTION APAC: Understanding perceptions, attitudes and behaviours in obesity and its management across south and Southeast Asia.亚太行动:了解南亚和东南亚地区对肥胖及其管理的认知、态度和行为。
Clin Obes. 2024 Jun;14(3):e12644. doi: 10.1111/cob.12644. Epub 2024 Feb 8.
3
Results of the ACTION-IO survey in Chilean patients with obesity and health care providers.智利肥胖症患者和医疗保健提供者 ACTION-IO 调查结果。
Rev Med Chil. 2021 Feb;149(2):217-228. doi: 10.4067/s0034-98872021000200217.
4
Gaps to bridge: Misalignment between perception, reality and actions in obesity.弥合差距:肥胖症中观念、现实和行动之间的不一致。
Diabetes Obes Metab. 2019 Aug;21(8):1914-1924. doi: 10.1111/dom.13752. Epub 2019 May 3.
5
Perceptions, Attitudes, Behaviors, and Barriers to Effective Obesity Care in South Korea: Results from the ACTION-IO Study.韩国有效肥胖护理的认知、态度、行为及障碍:ACTION-IO研究结果
J Obes Metab Syndr. 2020 Jun 30;29(2):133-142. doi: 10.7570/jomes20013.
6
Misperceptions and barriers to obesity management: Italian data from the ACTION-IO study.肥胖管理的误解与障碍:来自ACTION-IO研究的意大利数据。
Eat Weight Disord. 2021 Apr;26(3):817-828. doi: 10.1007/s40519-020-00907-6. Epub 2020 May 8.
7
Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study.提供者和肥胖患者之间不同态度和经历的影响:全国行动研究的结果。
Postgrad Med. 2019 Jun;131(5):357-365. doi: 10.1080/00325481.2019.1620616. Epub 2019 Jun 3.
8
Perceptions, attitudes and barriers to obesity management: Japanese data from the ACTION-IO study.肥胖管理的认知、态度和障碍:ACTION-IO 研究中的日本数据。
J Diabetes Investig. 2021 May;12(5):845-858. doi: 10.1111/jdi.13427. Epub 2020 Nov 17.
9
Perceptions, Attitudes, and Barriers to Obesity Management in Spain: Results from the Spanish Cohort of the International ACTION-IO Observation Study.西班牙肥胖管理的认知、态度及障碍:国际ACTION-IO观察研究西班牙队列的结果
J Clin Med. 2020 Sep 2;9(9):2834. doi: 10.3390/jcm9092834.
10
Healthcare Professionals' Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries.医疗保健专业人员对糖尿病管理中血糖目标范围内时间使用的了解及态度:七国在线调查
Diabetes Ther. 2023 Aug;14(8):1399-1413. doi: 10.1007/s13300-023-01429-x. Epub 2023 Jun 18.

引用本文的文献

1
A Virtual Simulator to Improve Weight-Related Communication Skills for Health Care Professionals: Mixed Methods Pre-Post Pilot Feasibility Study.一种用于提高医疗保健专业人员与体重相关沟通技巧的虚拟模拟器:混合方法前后试点可行性研究。
JMIR Med Educ. 2025 Aug 15;11:e65949. doi: 10.2196/65949.
2
Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.替尔泊肽与利拉鲁肽作为饮食和运动辅助治疗肥胖或超重患者的成本效益:英国视角
Adv Ther. 2025 Aug 11. doi: 10.1007/s12325-025-03288-3.
3
Preferences for Body Weight-Related Terminology for People Living with Obesity: Results from the ACTION-DK Study.

本文引用的文献

1
Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review.抗肥胖药物:长期疗效与安全性:最新综述
World J Mens Health. 2021 Apr;39(2):208-221. doi: 10.5534/wjmh.200010. Epub 2020 Mar 9.
2
Lifestyle modification approaches for the treatment of obesity in adults.成人肥胖治疗的生活方式改变方法。
Am Psychol. 2020 Feb-Mar;75(2):235-251. doi: 10.1037/amp0000517.
3
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南。
肥胖症患者对与体重相关术语的偏好:ACTION-DK研究结果
Obes Facts. 2025 Jun 21:1-15. doi: 10.1159/000546218.
4
Patient and Cardiologist Perspectives on the Treatment of Patients With Concomitant ASCVD and Obesity.患者与心脏病专家对合并动脉粥样硬化性心血管疾病(ASCVD)和肥胖患者治疗的观点
J Patient Exp. 2025 May 20;12:23743735251342141. doi: 10.1177/23743735251342141. eCollection 2025.
5
Perceptions of anti-obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study.美国肥胖人群和医疗服务提供者对抗肥胖药物的认知:OBSERVE研究结果
Obesity (Silver Spring). 2025 Jun;33(6):1076-1086. doi: 10.1002/oby.24290. Epub 2025 Apr 24.
6
General practitioner-centered rural obesity management: Design, protocol and baseline data of the German HAPpEN pragmatic trial.以全科医生为中心的农村肥胖管理:德国HAPpEN实用试验的设计、方案和基线数据。
Prev Med Rep. 2024 Dec 26;49:102959. doi: 10.1016/j.pmedr.2024.102959. eCollection 2025 Jan.
7
Exploring Racial and Ethnic Differences in Utilization of Medications for Obesity Management in a Nationally Representative Survey.在一项具有全国代表性的调查中探索肥胖管理药物使用方面的种族和民族差异。
J Racial Ethn Health Disparities. 2024 Dec 17. doi: 10.1007/s40615-024-02248-x.
8
Anti-obesity treatment preferences of healthcare providers and people living with obesity: A survey-based study.医疗服务提供者和肥胖症患者的抗肥胖治疗偏好:一项基于调查的研究。
Clin Obes. 2025 Feb;15(1):e12704. doi: 10.1111/cob.12704. Epub 2024 Oct 28.
9
Attitudes and knowledge about weight management among primary care physicians in Israel: a cross-sectional study.以色列初级保健医生对体重管理的态度和知识:一项横断面研究。
BMC Prim Care. 2024 Mar 19;25(1):92. doi: 10.1186/s12875-024-02324-5.
10
Nutritional Status, Selected Nutrients Intake, and Metabolic Disorders in Bariatric Surgery Patients.肥胖症患者的营养状况、特定营养素摄入量和代谢紊乱。
Nutrients. 2023 May 26;15(11):2479. doi: 10.3390/nu15112479.
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
4
Gaps to bridge: Misalignment between perception, reality and actions in obesity.弥合差距:肥胖症中观念、现实和行动之间的不一致。
Diabetes Obes Metab. 2019 Aug;21(8):1914-1924. doi: 10.1111/dom.13752. Epub 2019 May 3.
5
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.基层医疗主导的体重管理干预措施对 2 型糖尿病缓解的持久性:DIRECT 开放性标签、整群随机试验的 2 年结果。
Lancet Diabetes Endocrinol. 2019 May;7(5):344-355. doi: 10.1016/S2213-8587(19)30068-3. Epub 2019 Mar 6.
6
Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial.肥胖的强化行为治疗联合利拉鲁肽 3.0mg:一项随机对照试验。
Obesity (Silver Spring). 2019 Jan;27(1):75-86. doi: 10.1002/oby.22359. Epub 2018 Nov 13.
7
Forecasting Future Trends in Obesity across Europe: The Value of Improving Surveillance.预测欧洲肥胖未来趋势:改善监测的价值。
Obes Facts. 2018;11(5):360-371. doi: 10.1159/000492115. Epub 2018 Oct 12.
8
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).2018 年美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告:2 型糖尿病患者高血糖的管理。
Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5.
9
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon.肥胖的未来药物治疗:新的抗肥胖药物即将问世。
Curr Obes Rep. 2018 Jun;7(2):147-161. doi: 10.1007/s13679-018-0300-4.
10
Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study.有效肥胖症护理的障碍认知:全国行动研究的结果
Obesity (Silver Spring). 2018 Jan;26(1):61-69. doi: 10.1002/oby.22054. Epub 2017 Oct 31.